Patrick Donnelly
Stock Analyst at Citigroup
(3.32)
# 1,016
Out of 5,241 analysts
359
Total ratings
44.79%
Success rate
3.46%
Average return
Main Sectors:
Stocks Rated by Patrick Donnelly
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MTD Mettler-Toledo International | Maintains: Buy | $1,700 → $1,550 | $1,031.64 | +50.25% | 16 | May 8, 2026 | |
| CAI Caris Life Sciences | Maintains: Buy | $35 → $28 | $14.55 | +92.44% | 3 | May 8, 2026 | |
| BRKR Bruker | Maintains: Neutral | $40 → $44 | $42.88 | +2.61% | 20 | May 7, 2026 | |
| MDLN Medline | Maintains: Buy | $60 → $55 | $36.19 | +51.98% | 4 | May 7, 2026 | |
| TECH Bio-Techne | Maintains: Buy | $80 → $70 | $43.30 | +61.66% | 14 | May 7, 2026 | |
| QDEL QuidelOrtho | Maintains: Neutral | $30 → $13 | $10.32 | +25.97% | 8 | May 6, 2026 | |
| FTRE Fortrea Holdings | Maintains: Buy | $16 → $20 | $13.66 | +46.41% | 6 | May 6, 2026 | |
| ILMN Illumina | Maintains: Sell | $80 → $95 | $142.54 | -33.35% | 18 | May 4, 2026 | |
| AVTR Avantor | Maintains: Neutral | $11 → $9 | $7.62 | +18.11% | 10 | Apr 30, 2026 | |
| QGEN Qiagen | Maintains: Neutral | $55 → $38 | $32.98 | +15.22% | 16 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $18 → $24 | $21.20 | +13.21% | 14 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $375 → $300 | $247.53 | +21.20% | 18 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $375 → $300 | $260.90 | +14.99% | 18 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $200 → $120 | $116.38 | +3.11% | 11 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $26 | $17.99 | +44.52% | 5 | Mar 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $23 | $15.27 | +50.62% | 4 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $135 → $150 | $94.92 | +58.03% | 12 | Feb 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $190 → $215 | $186.61 | +15.21% | 12 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $230 → $200 | $169.12 | +18.26% | 14 | Feb 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $660 → $685 | $438.34 | +56.27% | 22 | Jan 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $200 → $265 | $150.85 | +75.67% | 22 | Jan 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $300 | $186.36 | +60.98% | 1 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $165 → $185 | $111.70 | +65.62% | 27 | Nov 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $265 | $161.91 | +63.67% | 12 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $135 → $145 | $93.97 | +54.30% | 1 | Jul 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $265 → $300 | $329.22 | -8.88% | 24 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $9 | $3.00 | +200.00% | 6 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.75 → $2.75 | $1.72 | +59.88% | 4 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $250 → $260 | $250.40 | +3.83% | 11 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $6 | $6.36 | -5.66% | 4 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $28 → $32 | $3.58 | +793.85% | 2 | Nov 30, 2018 |
Mettler-Toledo International
May 8, 2026
Maintains: Buy
Price Target: $1,700 → $1,550
Current: $1,031.64
Upside: +50.25%
Caris Life Sciences
May 8, 2026
Maintains: Buy
Price Target: $35 → $28
Current: $14.55
Upside: +92.44%
Bruker
May 7, 2026
Maintains: Neutral
Price Target: $40 → $44
Current: $42.88
Upside: +2.61%
Medline
May 7, 2026
Maintains: Buy
Price Target: $60 → $55
Current: $36.19
Upside: +51.98%
Bio-Techne
May 7, 2026
Maintains: Buy
Price Target: $80 → $70
Current: $43.30
Upside: +61.66%
QuidelOrtho
May 6, 2026
Maintains: Neutral
Price Target: $30 → $13
Current: $10.32
Upside: +25.97%
Fortrea Holdings
May 6, 2026
Maintains: Buy
Price Target: $16 → $20
Current: $13.66
Upside: +46.41%
Illumina
May 4, 2026
Maintains: Sell
Price Target: $80 → $95
Current: $142.54
Upside: -33.35%
Avantor
Apr 30, 2026
Maintains: Neutral
Price Target: $11 → $9
Current: $7.62
Upside: +18.11%
Qiagen
Apr 29, 2026
Maintains: Neutral
Price Target: $55 → $38
Current: $32.98
Upside: +15.22%
Apr 7, 2026
Maintains: Neutral
Price Target: $18 → $24
Current: $21.20
Upside: +13.21%
Apr 7, 2026
Downgrades: Neutral
Price Target: $375 → $300
Current: $247.53
Upside: +21.20%
Apr 7, 2026
Downgrades: Neutral
Price Target: $375 → $300
Current: $260.90
Upside: +14.99%
Mar 11, 2026
Maintains: Neutral
Price Target: $200 → $120
Current: $116.38
Upside: +3.11%
Mar 5, 2026
Maintains: Buy
Price Target: $32 → $26
Current: $17.99
Upside: +44.52%
Feb 24, 2026
Maintains: Buy
Price Target: $21 → $23
Current: $15.27
Upside: +50.62%
Feb 20, 2026
Maintains: Buy
Price Target: $135 → $150
Current: $94.92
Upside: +58.03%
Feb 10, 2026
Maintains: Neutral
Price Target: $190 → $215
Current: $186.61
Upside: +15.21%
Feb 6, 2026
Maintains: Neutral
Price Target: $230 → $200
Current: $169.12
Upside: +18.26%
Jan 30, 2026
Maintains: Buy
Price Target: $660 → $685
Current: $438.34
Upside: +56.27%
Jan 16, 2026
Maintains: Buy
Price Target: $200 → $265
Current: $150.85
Upside: +75.67%
Jan 7, 2026
Initiates: Buy
Price Target: $300
Current: $186.36
Upside: +60.98%
Nov 25, 2025
Maintains: Buy
Price Target: $165 → $185
Current: $111.70
Upside: +65.62%
Jan 30, 2025
Maintains: Buy
Price Target: $285 → $265
Current: $161.91
Upside: +63.67%
Jul 30, 2024
Maintains: Buy
Price Target: $135 → $145
Current: $93.97
Upside: +54.30%
Dec 11, 2023
Maintains: Neutral
Price Target: $265 → $300
Current: $329.22
Upside: -8.88%
Dec 11, 2023
Maintains: Buy
Price Target: $7 → $9
Current: $3.00
Upside: +200.00%
Aug 10, 2023
Maintains: Neutral
Price Target: $3.75 → $2.75
Current: $1.72
Upside: +59.88%
Feb 17, 2023
Maintains: Neutral
Price Target: $250 → $260
Current: $250.40
Upside: +3.83%
Nov 3, 2022
Maintains: Buy
Price Target: $8 → $6
Current: $6.36
Upside: -5.66%
Nov 30, 2018
Upgrades: Neutral
Price Target: $28 → $32
Current: $3.58
Upside: +793.85%